Related Experiment Video
Updated: Apr 13, 2026
12:40
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
Published on: December 7, 2014
15.4K
Targeting cancer with kinase inhibitors
The Journal of Clinical Investigation
|May 2, 2015
Summary
Selective kinase inhibitors are revolutionizing cancer treatment, with over 25 approved drugs. This review details kinase activation, drug discovery successes, clinical impact, resistance strategies, and future directions including immunotherapy.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Kinase inhibitors are crucial in treating cancer and other diseases.
- Over 25 kinase-targeting oncology drugs are approved, with more in clinical trials.
Purpose of the Study:
- To analyze kinase activation mechanisms in cancer.
- To review drug discovery successes and clinical impact of selective kinase inhibitors.
- To discuss next-generation inhibitors, resistance mechanisms, and combination strategies.
Main Methods:
- In-depth analysis of kinase activation.
- Review of recent drug discovery and clinical data.
- Exploration of resistance mechanisms and combination therapies.
Main Results:
- Selective kinase inhibitors demonstrate significant clinical impact.
- Progress in designing next-generation inhibitors to overcome resistance.
- Emerging strategies for combining kinase inhibitors in clinical practice.
Conclusions:
- Kinase inhibitors are a cornerstone of modern cancer therapy.
- Future research includes novel kinase targets and cancer immunotherapy.
- Continued development of kinase inhibitors promises improved patient outcomes.
Related Concept Videos
02:57Targeted Cancer Therapies
9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.2K
02:57Targeted Cancer Therapies
1.8K
1.8K
02:34Inhibition of Cdk Activity
6.2K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
02:34Inhibition of CDK Activity
5.7K
5.7K
02:50Combination Therapies and Personalized Medicine
6.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
01:27Transducer Mechanism: Enzyme-Linked Receptors
5.0K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
5.0K